HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members.

Abstract
Recent studies indicate that dysregulation of the Akt/PKB family of serine/threonine kinases is a prominent feature of many human cancers. The Akt/PKB family is composed of three members termed Akt1/PKBalpha, Akt2/PKBbeta, and Akt3/PKBgamma. It is currently not known to what extent there is functional overlap between these family members. We have recently identified small molecule inhibitors of Akt. These compounds have pleckstrin homology domain-dependent, isozyme-specific activity. In this report, we present data showing the relative contribution that inhibition of the different isozymes has on the apoptotic response of tumor cells to a variety of chemotherapies. In multiple cell backgrounds, maximal induction of caspase-3 activity is achieved when both Akt1 and Akt2 are inhibited. This induction is not reversed by overexpression of functionally active Akt3. The level of caspase-3 activation achieved under these conditions is equivalent to that observed with the phosphatidylinositol-3-kinase inhibitor LY294002. We also show that in different tumor cell backgrounds inhibition of mammalian target of rapamycin, a downstream substrate of Akt, is less effective in inducing caspase-3 activity than inhibition of Akt1 and Akt2. This shows that the survival phenotype conferred by Akt can be mediated by signaling pathways independent of mammalian target of rapamycin in some tumor cell backgrounds. Finally, we show that inhibition of both Akt1 and Akt2 selectively sensitizes tumor cells, but not normal cells, to apoptotic stimuli.
AuthorsDeborah DeFeo-Jones, Stanley F Barnett, Sheng Fu, Paula J Hancock, Kathleen M Haskell, Karen R Leander, Elizabeth McAvoy, Ronald G Robinson, Mark E Duggan, Craig W Lindsley, Zhijian Zhao, Hans E Huber, Raymond E Jones
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 4 Issue 2 Pg. 271-9 (Feb 2005) ISSN: 1535-7163 [Print] United States
PMID15713898 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Chromones
  • Morpholines
  • Protein Isoforms
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • 3-Phosphoinositide-Dependent Protein Kinases
  • AKT1 protein, human
  • AKT2 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Sirolimus
Topics
  • 3-Phosphoinositide-Dependent Protein Kinases
  • Antibiotics, Antineoplastic (pharmacology)
  • Apoptosis (physiology)
  • Caspase 3
  • Caspases (metabolism)
  • Chromones (pharmacology)
  • Drug Resistance, Neoplasm (drug effects)
  • Enzyme Activation
  • Humans
  • Morpholines (pharmacology)
  • Neoplasms (enzymology)
  • Protein Isoforms (chemistry, pharmacology)
  • Protein Kinase Inhibitors (chemistry, pharmacology)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, physiology)
  • Proto-Oncogene Proteins (antagonists & inhibitors, physiology)
  • Proto-Oncogene Proteins c-akt
  • Sirolimus (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: